Patients with NDAS are characterized by increased IFN and NF-κB response gene signatures and a lack of cardinal features, such as basal ganglia calcifications, white matter disease, and hypertension seen in other type I interferonopathies (6, 33). The gene discussed is NFKB1; the disease is Hypertension.